Pasar al contenido

Para fabricantes Póngase en contacto con nosotros

Español

¿Qué es Wellmune?
Productos
Investigación
Salud inmunitaria
Blog y noticias

¿Qué es Wellmune?
Productos que contienen Wellmune
Investigación
Blog y noticias
Salud inmunitaria
Para fabricantes
Póngase en contacto con nosotros: para fabricantes y distribuidores

Blog y noticias

mywhey logo

Publicado el octubre 29, 2019

Relacionado con:

Podemos ayudar.

Establezca un vínculo entre sus productos

y una buena &salud inmunitaria.

Póngase en contacto con nosotros

seguro natural clínicamente probado

Wellmune^®es una marca registrada de Kerry Group. © Kerry, 2017. Todos los derechos reservados.

Inicio • Política de privacidad • Política de cookies • Legal • Acerca de nosotros • Noticias

Wellmune forma parte del portafolio de productos nutricionales y para el bienestar de Kerry.

This international website provides information that is only intended to provide scientific and educational and for business-to-business use. The information contained herein is based on our current knowledge and contains scientific, quality and technical information to help our trade customers to understand more about our “food” ingredients and the science behind them. All content referenced is reflective of what is considered appropriate for the U.S. market where the site content is maintained and may not align with regulations outside the U.S. Not all statements have been evaluated by the U.S. FDA, European Food Safety Authority or the European Commission or any other applicable regulatory body. The products described are not intended to diagnose, treat or prevent any disease. It is your responsibility to comply with all relevant national laws when issuing commercial communications directed at consumers about any finished products containing these ingredients. EU and country specific legislation should also be considered when labelling and/or advertising to final consumers.

© 2024 Wellmune®. All rights reserved. Wellmune is part of Kerry’s ProActive Health portfolio.